PhRMA
This article was originally published in The Tan Sheet
Executive Summary
The possibility of working with FDA on dietary supplement regulation/policy was a topic slated for discussion at the annual strategic planning session of the PhRMA board meeting in Chantilly, Va. Nov. 11-12. It appears the trade group sees supplement regulation as a possible common ground on which to build future relations with the agency. Although a handful of PhRMA members market supplement products in the U.S., the majority may look favorably upon an organized effort to squelch supplement claims or increase enforcement actions allowed under DSHEA. Maneuvering could be tricky, however, as one of PhRMA's primary supporters on Capitol Hill - Sen. Orrin Hatch (R-Utah) -also is a staunch advocate of dietary supplements
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning